Chronic inducible urticaria

CIndU · Immunology · 1 drugs · 1 indications

Competitive Landscape (1 drugs)
DrugCompanyMechanismModalityRouteStage
RemibrutinibNVSBTK inhibitorSmall moleculeOralFILED
Indications (1)
Chronic inducible urticaria
Remibrutinib FILED
Upcoming Catalysts
Remibrutinib - Hidradenitis Suppurativa - Ph3 - ToplineCLINICAL
NVSH2 2026
Remibrutinib - CIndU - Ph3 - ToplineCLINICAL
NVSH2 2026
Data from Supabase · Updated 2026-03-24